Aktuellt
SENASTE
Redeye maintains its positive view on LIDDS after the report today. The management and the board have defined a sharper vision and a clearer strategic direction of the company, also with the goal to put a sustainable financing solution in place. The projects are advancing according to plan, with a stronger focus on immunooncology. LIDDS is playing for the long run.
LÄS MER
